Research / TOMZ / Fundamental state Inspectable configuration
State dimensions Filing 0001654954-26-003091 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
55.63% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 30th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.09% · OPTIONAL · VALID
Operating cash generation 47th Own-history percentile · N=17
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-21.23% · OPTIONAL · VALID
Revenue growth 23th Own-history percentile · N=13
Evidence method Yoy · gp.fundamentals.revenue
-27.17% · CORE · VALID
Inventory pressure 6th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
51.92% · OPTIONAL · VALID
Gross margin 6th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.gross_margin
54.60% · CORE · VALID
Operating margin 18th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.operating_margin
-68.39% · CORE · VALID
R&D intensity 59th Own-history percentile · N=17
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
5.14% · OPTIONAL · VALID
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
2.61% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 20 states Self-history eligible
Sep 30, 2021 0/6 normalized Level 3 Dec 31, 2021 0/5 normalized Level 3 Mar 31, 2022 0/5 normalized Level 3 Jun 30, 2022 0/5 normalized Level 3 Sep 30, 2022 0/7 normalized Level 3 Dec 31, 2022 0/7 normalized Level 3 Mar 31, 2023 0/7 normalized Level 3 Jun 30, 2023 0/7 normalized Level 3 Sep 30, 2023 5/7 normalized Level 3 Dec 31, 2023 5/8 normalized Level 3 Mar 31, 2024 5/6 normalized Level 3 Jun 30, 2024 5/6 normalized Level 3 Sep 30, 2024 6/7 normalized Level 3 Dec 31, 2024 6/8 normalized Level 3 Mar 31, 2025 6/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/8 normalized Level 3 Dec 31, 2025 7/9 normalized Level 3 Mar 31, 2026 7/9 normalized Level 3 Jun 30, 2026 7/9 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 0.00%
Current 0.09%
Delta 0.09% Cash Generation Decreased
Previous -5.64%
Current -21.23%
Delta -15.59% Growth Decreased
Previous -20.88%
Current -27.17%
Delta -6.30% Inventory Pressure Decreased
Previous 167.23%
Current 51.92%
Delta -115.31% Margin Decreased
Previous 61.24%
Current 54.60%
Delta -6.65% Profitability Decreased
Previous -15.98%
Current -68.39%
Delta -52.41% R And D Intensity Increased
Previous 0.53%
Current 5.14%
Delta 4.61% Sbc Intensity Increased
Previous 0.00%
Current 2.61%
Delta 2.61% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.